StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

2-Hydroxyethylsalicylat

Glycol Salicylate

HCID 6880
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
87-28-5
Standard-SMILES
O=C(OCCO)c1ccccc1O
InChIKey
LVYLCBNXHHHPSB-UHFFFAOYSA-N
Summenformel
C9H10O4
Durchschnittliche Molmasse
182,17 g/mol
Monoisotopische Masse
182,0579088

Überblick

2-hydroxyethyl salicylate is a benzoate ester obtained by the formal condensation of carboxy group of salicylic acid with one of the hydroxy groups of ethylene glycol. It is a primary alcohol, a member of salicylates and a member of phenols. It is functionally related to a salicylic acid and an ethylene glycol.

Namen und Bezeichner

Bevorzugter Name
Glycol Salicylate
IUPAC
2-hydroxyethyl 2-hydroxybenzoate
Lokaler Name
2-Hydroxyethylsalicylat
Englischer Name
2-Hydroxyethyl salicylate
Summenformel
C9H10O4
Molmasse
182.17

Namen und Synonyme

2-Hydroxyethyl salicylate87-28-52-Hydroxyethyl 2-hydroxybenzoateGLYCOL SALICYLATEEthylene glycol monosalicylateGlycol monosalicylatehydroxyethyl salicylateEthylene glycol salicylateBenzoic acid, 2-hydroxy-, 2-hydroxyethyl ester2-Hydroxybenzoic acid 2-hydroxyethyl esterSalicylic acid, 2-hydroxyethyl esterDTXSID4048987
Weitere Namen anzeigen
GLYSALClemastine Impurity 7Mono Ethylene Glycol SalicylateGL 7SarocolmonosaLSpirosal
2-hydroxyethyl 2-oxidanylbenzoate3I1VBB7AXHNSC-720972-Hydroxybenzoic acid, 2-hydroxyethyl esterDTXCID4028913CHEBI:86541RefChem:663897ethyleneglycolmonosalicylic acid ester

Datenbank-Bezeichner

CAS
87-28-5
PubChem CID
6880
DTXSID

Eigenschaften

Berechnete Struktureigenschaften

XLogP
1,9
Polarare Oberfläche (TPSA)
66,8 Ų
H-Brücken-Donoren
2
H-Brücken-Akzeptoren
4
Frei drehbare Bindungen
4
Schwere Atome
13
Formalladung
0
Komplexität
169

Experimentelle und physikochemische Eigenschaften

DrugsPharmaceuticals -> Listed in ZINC15
CosmeticsUv absorber

Physikochemische Eigenschaften

Schmelzpunkt
26 °C · 26 °C
Siedepunkt
172 °C/12 · 172 °C/12 mmHg
Dichte
1.244 g/mL · 1.244 g/mL at 25 °C (lit.)
Dampfdruck
0.0001 hPa · 0.0001 hPa (20 °C)
Brechungsindex
20 · n 20/D 1.548 (lit.)
Flammpunkt
171 °C · 171 °C - DIN 51758
storage temp.
30 °C · Store below +30°C.
Löslichkeit
13.1 g/l · 13.1g/l
Aggregatzustand
powder to lump to clear liquid
pka
8 · 8.00±0.30(Predicted)
Farbe
White or Colorless to Almost white or Almost colorless

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 50 reports by companies from 4 notifications to the ECHA C&L Inventory.

Gefahrenhinweise

Regulatory Information · 2 Einträge

Chemical: Benzoic acid, 2-hydroxy-, 2-hydroxyethyl ester

Glycol salicylate: Does not have an individual approval but may be used under an appropriate group standard

Hazard Classes and CategoriesAcute Tox. 4 (100%)

Sicherheitsdaten

wgk
3
tsca
TSCA listed
hs_code
2918230000
risk_code
22
Toxizität
LD50 orally in Rabbit: 1380 mg/kg
hazard_code
Xn
safety_code
44
Speicherklasse
10 - Combustible liquids
Hazard Classifications
Acute Tox. 4 Oral
Selbstentzündungstemperatur
441 °C DIN 51794

Chemie und Industrie

Pharmakologische Informationen

Protein BindingThe plasma protein binding of salicylic acid is concentration-dependent and subject to pronounced interindividual differences.
Pharmacodynamics · 1 Eintrag

Temporarily relieves minor to moderate aches and pains. Works with ingredients such as menthol, which has counter-irritant properties. Counter-irritants are externally applied, and lead to irritation or mild inflammation of the skin to relieve pain in muscles or joints by reducing inflammation in deeper adjacent structures. Counter-irritants relieve pain by disrupting the brain from receiving pain signals resulting from conditions such as osteoarthritis (OA) or injuries such as sprains or strains. These agents may cause vasodilatation or skin irritation, leading to a false sensation of heat or warmth.

Mechanism of Action · 1 Eintrag

Similar to other salicylates. Salicylates and other analgesics and anti-inflammatory drugs, particularly the non-steroidal anti-inflammatory drugs (NSAID) mainly used in rheumatology, inhibit cyclooxygenase, therefore reducing prostaglandin synthesis.

Biological Half-LifeThe serum half-life of [DB00945], a similar salicylate, is 20 min.
Metabolism/Metabolites · 1 Eintrag

The metabolism of glycol salicylate is similar to that of [DB00945] at other salicylates. Metabolism of salicylic acid occurs through glucuronide formation (to produce salicyl acyl glucuronide and salicyl phenolic glucuronide), conjugation with glycine (to produce salicyluric acid), and oxidation to gentisic acid. The rate of formation of salicyl phenolic glucuronide and salicyluric acid are readily saturated at low salicylic acid concentrations and their formation is described by Michaelis-Menten kinetics. The larger the dose administered, the longer it will take to reach steady-state concentrations of salicylates. There is also evidence that enzyme induction of salicyluric acid formation occurs during the metabolism of salicylates.

Absorption, Distribution and Excretion · 2 Einträge

Zugehörige Reaktionen

0
Reaktionsaufzeichnung erstellen
Noch keine zugehörigen Reaktionen

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
DTXSID4048987
ChEMBL
CHEMBL173562
ChEBI
CHEBI:86541
UNII
3I1VBB7AXH
EC Number
201-737-2
Nikkaji
J55.649A
Wichte
1.244 · 1.244 (20/4℃)
PH
4 · 4.0 (13.1g/l, H2O, 20℃)
Merck
14 · 14,4499
BRN
2255685 · 2255685
Kosmetik-Inhaltsstoffe Funktionen
UV ABSORBER
InChI
1S/C9H10O4/c10-5-6-13-9(12)7-3-1-2-4-8(7)11/h1-4,10-11H,5-6H2
InChIKey
LVYLCBNXHHHPSB-UHFFFAOYSA-N
SMILES
OCCOC(=O)c1ccccc1O
LogP
1.519 · 1.519 (est)
CAS Datenbank
87 · 87-28-5(CAS DataBase Reference)
NIST chemische Informationen
2 · 2-Hydroxyethyl salicylate(87-28-5)
EPA chemische Informationen
2 · Benzoic acid, 2-hydroxy-, 2-hydroxyethyl ester (87-28-5)

Salicylate absorption follows first-order kinetics with an absorption half-life ranging from 5 to 16 minutes.

Salicylates are generally excreted.

Verwendung und Herstellung

Use ClassificationCosmetics -> Uv absorber
General Manufacturing InformationBenzoic acid, 2-hydroxy-, 2-hydroxyethyl ester: INACTIVE

Anwendungen

VerwendenGlycol Salicylate, is a derivative of salicylic acid that has been proved to be able to improve the aesthetic appearance of the skin. It is also a building block used in various chemical synthesis.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

Benzoic acid, 2-hydroxy-, 2-chloroethyl esterEthylendisalicylatKaliumsalicylatSchwefelsureMethylsalicylat2-MethylbenzylalkoholPhenylsalicylat1,2-DibromethanNatriumsalicylat

Nachgelagerte Produkte

2-Hydroxybenzaldehyde ethylene acetal

Ergänzende Hinweise

DefinitionChEBI: A benzoate ester obtained by the formal condensation of carboxy group of salicylic acid with one of the hydroxy groups of ethylene glycol